Skip to content
Home
News
About Us
Mission & Vision
Message from the CEO
Company Profile
Members
Access
Science & Technology
What Are Diabetes Stem Cells?
Complete Remission of Diabetes.
What Is Biozipcode™?
Cell-Targeting Technology
Academic Collaboration Overview
Dep. of Biocommunication Development (Kyoto Univ)
Domestic & Inter. Research Collaborations
Pipeline Overview
Diabetes Remission Therapy Candidate
Diabetes Stem Cell Biomarker
Biozipcode™ Cell-Targeted Diabetes Therapy
Cell-Targeted Oncology Therapeutics
Cell-Targeted Tissue Regeneration
Research Achievements
Selected Publications
Patents & Intellectual Property
Videos, Lectures & Presentations
For Partners
For Pharmaceutical Com. & Research Instit.
Research Collaboration
Technology Licensing
Co-development
Investment & Strategic Partnerships
Downloads
Contact
Contact Form
Legal & Policies
Privacy Policy
Website Policy
Cookie Policy
Medical & Scientific Disclaimer
Conflict of Interest & Transparency Policy
Japanese
Japanese
All News
All News
All News
biozipadmin
2026-09-26T13:21:39+09:00
News
Announcement of the Relocation of the Department of Biocommunication Development to Kyoto University and the Launch of Joint Industry–Academia Research
Announcement of the Relocation of the Department of Biocommunication Development to Kyoto University and the Launch of Joint Industry–Academia Research
2026-04-01
ニュース
2022-09-12
会社株式会社バイオジップコード「BioJapan2022」に出展
Read Article
News
2022-09-01
Announcement of a Seminar by Hideto Kojima, Head of Research and Development at Biozipcode, Inc. — “Say Goodbye to Diabetes!”
Read Article
ニュース
2022-09-01
株式会社バイオジップコード 研究開発責任者小島秀人氏のセミナー開催のお知らせ ~「糖尿病にさようなら!」~
Read Article
News
2022-04-18
Biozipcode, Inc. Announces Acquisition of Rights Related to International Patent Applications for Diabetes Treatments
Read Article
News
2022-01-01
Launch of the Biozipcode, Inc. Website
Read Article
Previous
1
2
Page load link
Go to Top